Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept study.
René J BoosmanNikki de RouwAlwin D R HuitemaJacobus A BurgersRob Ter HeinePublished in: British journal of clinical pharmacology (2022)
We show that test dosing of pemetrexed is feasible, but there seems no added value for a low test dosing in the dose individualization of pemetrexed.